CARLOS
LOPEZ LARREA
Catedrático de Universidad
Hospital Virgen de la Arrixaca
Murcia, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Virgen de la Arrixaca (7)
2021
-
Bromodomain protein BRD4 is an epigenetic activator of B7-H6 expression in acute myeloid leukemia
OncoImmunology, Vol. 10, Núm. 1
2017
-
Increasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognition
Oncotarget, Vol. 8, Núm. 19, pp. 31959-31976
2013
-
DNA Methylation Dynamics in Blood after Hematopoietic Cell Transplant
PLoS ONE, Vol. 8, Núm. 2
2007
-
The relationship of anti-MICA antibodies and MICA expression with heart allograft rejection
American Journal of Transplantation, Vol. 7, Núm. 7, pp. 1842-1848
2006
-
Post-transplant soluble MICA and MICA antibodies predict subsequent heart graft outcome
Transplant Immunology, Vol. 17, Núm. 1, pp. 43-46
-
The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection
Transplantation, Vol. 82, Núm. 3, pp. 354-361